CASI Pharmaceuticals Inc. (CASI) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear

CASI Pharmaceuticals Inc.

NASDAQ: CASI · Real-Time Price · USD
1.31
-0.20 (-13.30%)
At close: Sep 26, 2025, 3:59 PM
1.32
0.70%
After-hours: Sep 26, 2025, 07:58 PM EDT

CASI Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-39.26M -26.94M -40.26M -35.84M
Depreciation & Amortization
2.33M 3.74M 2.42M 1.81M
Stock-Based Compensation
1.31M 7.22M 7.01M 7.77M
Other Working Capital
1.86M -2.06M -315K 1M
Other Non-Cash Items
5.63M 3.83M 16.39M 7.83M
Deferred Income Tax
n/a n/a n/a -5.2M
Change in Working Capital
771K -7.82M -6.65M -3.22M
Operating Cash Flow
-29.22M -19.97M -21.09M -26.84M
Capital Expenditures
-240K -2.24M -5.61M -15.5M
Cash Acquisitions
-1.37M n/a 138K 10K
Purchase of Investments
-1.41M -51.75M -7.42M -12.4M
Sales Maturities Of Investments
13.76M 44.32M 37.62M 172K
Other Investing Acitivies
483K -2.04M 6.44M 7.03M
Investing Cash Flow
11.24M -9.67M 31.16M -20.69M
Debt Repayment
n/a n/a n/a -839K
Common Stock Repurchased
n/a -278K -3.27M n/a
Dividend Paid
-718K n/a n/a n/a
Other Financial Acitivies
1.15M -738K n/a -2.02M
Financial Cash Flow
15.43M -907K -3.27M 29.64M
Net Cash Flow
-3.62M -30.03M 8.41M -18.36M
Free Cash Flow
-29.46M -22.21M -26.7M -42.34M